ICW Makes a Substantial Strategic Commitment to Focus on the U.S. Market

InterComponentWareInterComponentWare AG (ICW), an international eHealth company headquartered in Walldorf, Germany, has invested substantially over the last two years to strongly focus on the current and future needs of the U.S. healthcare market, especially in the areas of Care Coordination and Care Management. Based on its mature, best-of-breed Health Information Exchange (HIE) and Master Patient Index (MPI) solutions, ICW has developed care management applications supporting care pathways across all venues, as well as applications for collaborative care coordination. Due to its considerable progress, ICW has decided to reopen their operations in the U.S with teams in business development, sales and product management. ICW Inc. is headquartered in Bala Cynwyd, PA, includes key representatives in the Northeast and Silicon Valley, and is led by board members Peter J. Kirschbauer (Chairman & CEO), Nils Effertz (Chief Business Development Officer & COO) and Matthias Glück (Chief Financial Officer), along with top U.S. industry advisors.

"The U.S. Health Information Technology (HIT) market has made tremendous progress over the past years and its dynamics provide excellent opportunities for us. We're excited about supporting critical progress in underlying technologies, a plethora of care delivery applications, and multiple stakeholder collaborations within a U.S. healthcare system that is increasingly shifting from fee-for-service to fee-for-value. Our go-to-market strategy will be centered around key strategic partnerships, which, as part of sustainably growing our U.S. organization, we'll complement with select direct initiatives to work closely with our valued U.S. customers in order to meet their needs and gather best practices for IT adoption in healthcare ," says Nils Effertz.

ICW delivers solutions ideally suited for risk bearing healthcare organizations such as Accountable Care Organizations (ACO), as well as Integrated Delivery Networks (IDN), Health Systems and HIE focused organizations. ICW's products are offered both via one-time and subscription-based licensing, benefiting from 15 years of strong HIT software development expertise from its Germany-based parent company, ICW AG.

"This is a great time to partner and work with ICW. We're convinced that ICW is at the beginning of a U.S. growth cycle and we’ll be 100% focused on helping our partners and clients succeed in adopting HIT that is fully aligned with their strategic goals and gets us closer to achieving the triple aim of healthcare: better care, lower costs and improved outcomes. ICW's full commitment to the U.S. is fostered by our strong belief that a majority of our revenue will come from the U.S. market over the next years," states Peter J. Kirschbauer.

Related news articles:

About InterComponentWare AG
We are a privately owned international software company with over 15 years of experience in the field of Healthcare IT. We are headquartered in Walldorf, Germany, have our own subsidiary in the U.S. and are strongly U.S. market focused. We build efficient and reliable solutions to improve the quality and efficiency of care across the entire care continuum. Our solutions enable healthcare organizations to leverage innovative models for cross-enterprise care coordination and patient-centric care delivery. We apply state-of-the-art software technology to develop robust and highly scalable applications with a strong focus on optimal user experience. We support the most advanced communication and interoperability standards by design, and turn seamless integration into a straightforward process. Together with our partners, we deliver safe and sustainable solutions for more than 20 million patients across the United States, Germany and Switzerland.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...